Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ana Bronić"'
Publikováno v:
Journal of Medical Biochemistry
Journal of Medical Biochemistry, Vol 40, Iss 2, Pp 138-149 (2021)
Journal of Medical Biochemistry, Vol 40, Iss 2, Pp 138-149 (2021)
In the final phase of clot formation, fibrinogen constitutes frame, whereas factor XIII (FXIII) active form is responsible for the covalent cross-linking of fibrin fibres and plasmin inhibitor (PI), thus contributing to clot stability. It could be ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a97b49bbefc98cae6a0c3596593ff5b8
https://doi.org/10.5937/jomb0-26839
https://doi.org/10.5937/jomb0-26839
Autor:
Branka Krešić, Marija Milić, Desiree Coen Herak, Vanja Radišić Biljak, Ana Bronić, Jasna Leniček Krleža, Sandra Margetić
Publikováno v:
Biochemia Medica
Volume 31
Issue 2
Volume 31
Issue 2
Introduction: Activated partial thromboplastin time (aPTT) is determined and reported as clotting time in seconds aPTT(s), but it is presumed that reporting results as patient-to- normal clotting time ratio, aPTT(r), could minimize within- laboratory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06cba86e2b7931452ac87c9483926208
https://www.bib.irb.hr/1143957
https://www.bib.irb.hr/1143957
Publikováno v:
Biochemia Medica
Volume 30
Issue 1
Volume 30
Issue 1
Introduction: Appropriate iodine intake is important for the entire population, especially in fertile women due to decisive role of thyroid hormones in normal foetal brain development. The aim of this study was to investigate knowledge on iodine role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f8ab8257e021b8037cbe954f24b70fd
https://hrcak.srce.hr/234145
https://hrcak.srce.hr/234145
Publikováno v:
Biochemia Medica
Volume 29
Issue 2
Volume 29
Issue 2
A modern diagnostic laboratory offers wide spectrum of coagulation assays utilized in the diagnosis and management of patients with haemostatic disorders, preoperative screening and anticoagulation therapy monitoring. The recent survey conducted amon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c7db440c275188b45eb030c64394f8e
http://europepmc.org/articles/PMC6559624
http://europepmc.org/articles/PMC6559624
Publikováno v:
Biochemia Medica
Volume 27
Issue 1
Volume 27
Issue 1
Introduction: The objective of this survey was to assess current policies and practice in haemostasis testing among both hospital and outpatient laboratories in Republic of Croatia. Materials and methods: A questionnaire with seventy questions divide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::824fb15c668f8faaaffc45adf93ede54
https://doi.org/10.11613/bm.2017.022
https://doi.org/10.11613/bm.2017.022
Autor:
Desiree Coen Herak, Renata Zadro, Vlatka Mejaški-Bošnjak, Vlasta Đuranović, Ana Bronić, Jasna Leniček Krleža
Publikováno v:
Croatian Medical Journal
Volume 54
Issue 4
Volume 54
Issue 4
Aim To determine the frequency of inherited and acquired prothrombotic risk factors in children with arterial ischemic stroke (AIS) and transient ischemic attacks (TIA) in Croatia. Methods We investigated 14 prothrombotic risk factors using blood sam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5530281c8237da86b887bf067ee78486
https://doi.org/10.3325/cmj.2013.54.346
https://doi.org/10.3325/cmj.2013.54.346
Publikováno v:
Medicinski vjesnik
Volume 48
Issue (1-2)
Volume 48
Issue (1-2)
Uvod: Promjene u sustavu hemostaze mogu pridonijeti razvoju tromboembolijskih i hemoragijskih bolesti. Stoga je glavni cilj ovoga rada bio istražiti povezanost koagulacijskih pretraga koje se uobičajeno određuju po prijemu bolesnika s akutnim mož
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______951::0f9bcdabd38f2893a3fd748e15285b2e
https://hrcak.srce.hr/file/327243
https://hrcak.srce.hr/file/327243
Publikováno v:
Molecular Biology Reports. 36:1-5
Arterial thrombosis is the major reason for severe complications of coronary artery disease (CAD). Recently it has been suggested that the FXIII-A Val34Leu polymorphism, affecting clot stability, provides protection against thrombosis. Results publis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f222794db6a88eedaf4979bd25ffc9d
https://doi.org/10.1007/s11033-007-9144-9
https://doi.org/10.1007/s11033-007-9144-9
Autor:
Jasna Leniček Krleža, Ana Bronić
Publikováno v:
Cardiologia Croatica
Volume 8
Issue 1-2
Volume 8
Issue 1-2
U prevenciji tromboembolijskih događaja različite etiologije, a stoga i kod pacijenata s fibrilacijom atrija (FA) te pacijenata s akutnim koronarnim sindromom (AKS) konvencionalno se primjenjuje acetilsalicilatna kiselina, heparini te antagonisti v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e51d09b4c3d79dd098b66b5878b5f691
https://hrcak.srce.hr/file/143962
https://hrcak.srce.hr/file/143962
Publikováno v:
Thrombosis Research. 133:S22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1309dfc047bb724d836ee547c9ae1ef6
https://doi.org/10.1016/s0049-3848(14)50091-6
https://doi.org/10.1016/s0049-3848(14)50091-6